Search results
Displaying 11 - 20 of 44 results
-
Gary's story: a consumer perspective on taking warfarin
This is the story of Gary Edwards, a 60-year-old builder from Waitarere Beach, who ended up on Warfarin after a cardiac event.
-
Applying for specify brand advice status
Use this application form to apply for a new or changed specify brand advice listing.
-
Reducing opioid-related harm and building quality improvement capability in New Zealand: a national formative collaborative
This poster 'Reducing opioid-related harm and building quality improvement capability in New Zealand: a national formative collaborative' was presented at the IHI's 28th annual national forum on quality improvement in health care.
-
Pharmac leaflet explaining medicine brand changes
This leaflet from Pharmac explains why brand names, appearance and packaging of your medicines may have changed.
-
Metoprolol oral administration - draft alert
The Medication Safety Expert Advisory Group is developing a full alert following release of a safety signal issued in October 2012 on oral metoprolol administration.
-
Acetylcysteine for the treatment of paracetamol overdose and toxicity – 2-bag dosing guidance
New dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.
-
Evaluation of the safe use of opioids national collaborative
This report presents an evaluation of the Health Quality & Safety Commission-led safe use of opioids national collaborative.
-
ALERT 17: Alteplase or tenecteplase?
An alert has been issued to highlight the need to clearly differentiate between stroke thrombolysis and myocardial infarction thrombolysis.
-
Safe use of opioids data collection and reporting workbook (manual data capture)
Spreadsheet template for manual data capture, for the safe use of opioids data collection and reporting.
-
Medicine reconciliation guidance tools and training materials
Medicine reconciliation guidance tools and training materials.